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Abstract
Background: Severe mental illness (SMI) presents a major burden to societies worldwide. Low- and middle-income
countries (LMICs) often do not have sufficient financial resources and qualified staff to provide extensive specialised
services for outpatients with SMI. Our research therefore aims to explore and test low-cost interventions that use
existing resources in routine patient-clinician meetings, families and communities.
Methods: In Bosnia-Herzegovina, Colombia and Uganda, three psychosocial interventions will be tested, i.e. making
patient-clinician meetings therapeutically effective through DIALOG+, family involvement in multi-family group
meetings, and support for patients in befriending schemes with volunteers. All interventions will be provided to
patients with SMI, delivered over a six-month period and evaluated with assessments at baseline and after six and
12 months. We will conduct nine trials including non-controlled trials, non-randomised controlled trials and
randomised controlled trials (RCTs). Core outcome criteria will be used across all studies. However, details of study
delivery and additional outcome criteria vary to accommodate local contexts, interests and priorities. The studies
will be analysed separately, but with the option to compare and combine findings.
Discussion: The approach provides the opportunity to learn from commonalities and differences in the results and
experiences across the three resource-oriented approaches and the three countries. If successfully implemented the
studies can lead to more extensive research and are expected to inform health policies and clinical practice of
community care for patients with SMI in the three participating countries and other LMICs.
Trial registration: All RCTs were registered prospectively and non-randomised trials retrospectively within the
ISRCTN Registry.
DIALOG+ in Uganda: ISRCTN25146122 (Date of Registration: 20/11/2018, prospective); DIALOG+ in Colombia:
ISRCTN83333181 (Date of Registration: 20/11/2018, prospective); DIALOG+ in Bosnia-Herzegovina: ISRCTN13347129 (Date of
Registration: 20/11/2018, prospective); Volunteer Support in Uganda: ISRCTN86689958 (Date of Registration: 04/03/2019,
retrospective); Volunteer Support in Colombia: ISRCTN72241383 (Date of Registration: 04/03/2019, retrospective);Volunteer
Support in Bosnia-Herzegovina: ISRCTN51290984 (Date of Registration: 20/11/2018, prospective); Family Involvement in
Uganda: ISRCTN78948497 (Date of Registration: 04/03/2019, retrospective); Family Involvement in Colombia: ISRCTN11440755
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Background
In order to address global challenges, significant
amounts of funding have been made available in
high-income countries (HICs) in the last five years to
conduct research with and in low- and middle-income
countries (LMICs). Much of this funding has been used
to support research in global health, including global
mental health [1]. There is no overall accepted consen-
sus on what exactly global mental health research should
entail. One approach is that research should aim to test
and implement evidence-based interventions in LMICs,
most of which have exclusively been studied in HICs [2].
Such an approach has limitations: a) using current
evidence-based interventions in a different context
might be inappropriate and ineffective, particularly as
most interventions in mental health care have only small
to medium effect sizes; b) many interventions, such as
the majority of formal psychological treatments, require
significant funding and qualified professional staff, none
of which is usually available in LMICs; and c) in various
LMICs there are likely to be resources in individuals,
families and communities, that may not exist to the
same extent in HICs but can be utilised to help people
alleviate or overcome the distress of mental disorders.
We therefore applied to the National Institute of
Health Research (NIHR) in the United Kingdom (UK)
to pursue a different approach. We were awarded
funding for a NIHR Global Health Research Group
on Developing Psycho-Social Intervention for Mental
Health Care at Bart’s and the London School of
Medicine and Dentistry (hereby referred to as The
Group). The Group aims to establish partnerships of
experts in HICs and LMICs, work in collaboration
with local stakeholders to develop resource-oriented
interventions for people with severe mental illness,
and to conduct studies to test these interventions [3].
The interventions are intended to be low-cost and
mainly use existing resources and social structures in
LMICs. Therefore, if found to be effective, the inter-
ventions should facilitate sustainable implementation
of effective community care for large numbers of
people with severe mental illness (SMI). The three
existing resources that we will utilise are a) contacts
and meetings between patients and clinicians in the
community as they occur in the given context; b)
families and friends of patients; and c) volunteers in
the community who are willing to spend time with
and support patients with SMI. The research designs
were all adapted and agreed with local stakeholders
to ensure they fit with the local context, priorities
and mental health needs. Through the work of the
Group, we also intend to increase the expertise in re-
search on psychosocial interventions in the partner
countries and more generally to advance the concep-
tual understanding of what global mental health re-
search may mean and achieve.
The Group consists of partners in Sarajevo (Bosnia--
Herzegovina), Bogotá (Colombia), Kampala (Uganda)
and London (UK). Bosnia-Herzegovina, Colombia and
Uganda are all LMICs, all have aims to expand commu-
nity care for people with SMI and all share a recent his-
tory of armed conflicts. Yet, they are on three different
continents and have different traditions and cultures.
This may facilitate the learning from commonalities and
differences in experiences.
Methods
Interventions and study designs
The research conducted by the Group will test three
aforementioned interventions - making patient-clin-
ician meetings therapeutically effective through DIA-
LOG+, family involvement in multi-family group
meetings, and support for patients in befriending
schemes with volunteers. Each intervention is tested
in each country, i.e. there are nine studies in total.
The study designs include non-controlled trials,
non-randomised controlled trials and smaller and lar-
ger randomised controlled trials (RCTs). The main
characteristics of the nine studies are summarised in
Table 1, indicating core consistencies and differences
in study designs across the three LMICs.
For each intervention (described below) there is some
evidence for effectiveness from HICs, although that evi-
dence is not always conclusive and does not necessarily
apply to the precise form of the intervention as used in
this research. Yet, all interventions can refer to theories
for why they might be beneficial to patients and have
been found by local stakeholders in each country to be
relevant for the given context.
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DIALOG+
DIALOG+ has been developed to turn routine meetings
between a patient and mental health professional into a
therapeutically effective intervention. It is based on qual-
ity of life research, concepts of patient-centred commu-
nication, developments in information technology, and
components of solution-focused therapy. Supported by
an App using a tablet computer, it delivers assessment,
planning, intervention and evaluation in one procedure.
In the meeting with the mental health professional, pa-
tients rate their satisfaction with eight quality of life do-
mains, and three treatment domains. The ratings are
summarised on-screen, allowing for comparisons with rat-
ings from any previous meeting. Patients can then decide
which life and/or treatment domains they would like to dis-
cuss in the current meeting. Each selected life domain or
treatment domain is addressed in a four-step solution-fo-
cused approach. The four steps are: 1) understanding (Why
is the patient dissatisfied? What is nevertheless working
well?); 2) looking forward (What is the best case scenario?
What is the smallest step forward?); 3) exploring options
(What can the patient, the mental health professional and
others do?); and finally 4) agreeing on actions (What should
be done between now and the next meeting?). The agreed
actions are briefly documented and revisited at the begin-
ning of the next meeting.
In an RCT in London, DIALOG+ was compared with
an active control condition and was shown to lead to
better quality of life, lower symptom levels, more
favourable objective social situation and reduced health
care costs for patients with schizophrenia [4–6].
DIALOG+ will be tested in three cluster rando-
mised controlled trials, in which mental health profes-
sionals and their patients, i.e. clusters, are randomly
allocated either to the experimental or the control
group. This design will prevent potential contamin-
ation effects between the groups and ensure that no
professional who is trained in DIALOG+ administers
it to a patient in the control group. DIALOG+ will
be delivered by mental health professionals, once per
month over a period of 6 months, as part of usual
routine clinical meetings.
In each country, DIALOG+ will be administered to out-
patients with SMI, diagnosed using International Classifi-
cation of Diseases, Tenth Revision (ICD-10) criteria [7] by
mental health professionals but with slight variations in
the diagnosis and patient numbers based on the priorities
expressed by national stakeholders and reflecting differ-
ences in national health and social care systems.
In Uganda, 168 patients with SMI defined as having been
diagnosed with psychosis, bipolar, and/or mood affective
disorders, (ICD-10 F20–29, F30-F39), epilepsy and/or co-
morbid substance abuse and 14 mental health professionals
including nurses, social workers, psychiatric clinical officers,
psychologists and psychiatrists will be part of the trial. The
RCT in Uganda will comprise of an active control arm. Pa-
tients in the control group will also receive an intervention
on a tablet, where they will be asked to complete the DIA-
LOG scale which includes only satisfaction ratings, with
minimal input from clinicians. This will be done at the end
of their routine sessions so that the ratings will not influ-
ence the communication during the meeting.
In Colombia, 168 patients with SMI defined as having
been diagnosed with psychosis, bipolar, and/or mood
affective disorders (ICD-10 F20–29, F31, F32) will be in-
cluded and all 14 mental health professionals will be
qualified psychiatrists or psychiatric residents.
In Bosnia, a RCT will be conducted with 72 patients
with severe depression and anxiety (ICD-10 F30-F39,
F40-F49, excluding bipolar disorder) and 14 mental
health professionals who will be qualified psychiatrists,
psychologists or psychiatric residents.
Family involvement
Involving family members or friends in patient’s care can
help to improve family communication, overall care and
outcomes. The intervention will draw from the tradition
of trialogue and psychosis-seminars, where mutual
learning occurs through the sharing of experiences, sup-
port and psychoeducation on pre-agreed topics [8, 9]. In
multi-family group meetings, approximately five to six
patients with one or two family members or friends each
and one or two mental health professionals will meet
and discuss subjects that are defined and selected by the
Table 1 Main characteristics of the nine studies that will be conducted in Bosnia-Herzegovina, Colombia and Uganda
Bosnia-Herzegovina Colombia Uganda
DIALOG+ Cluster RCT, 72 patients with
depression and anxiety, 14
clinicians, Control group = TAU
Cluster RCT, 168 patients with SMI,
14 clinicians, Control group = TAU
Cluster RCT, 168 patients with MNS,
14 clinicians, Active control group
Family Involvement RCT, 72 patients with SMI, 36–72
family members/friends, 6–12
clinicians, Control group = TAU
Non-controlled trial, 30 patients with
SMI, 30–60 family members/friends,
6–12 clinicians, No control group
Controlled trial, 30 patients with SMI,
30–60 family members/friends, 6–12
clinicians, Control site
Volunteer Support RCT, 72 patients with SMI, 36
Volunteers, Control group = TAU
Non-controlled trial, 30 patients with
SMI, 20 volunteers, No control group
Controlled trial, 30 patients with SMI,
10 volunteers, Control Site
Abbreviations: RCT Randomised controlled trial, SMI Severe mental illness, MNS Mental, neurological and substance misuse disorders, TAU Treatment as usual
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participants. The family intervention sessions will be
held once per month, over six months at local commu-
nity or health centres, or easily accessible locations.
The meetings will normally be chaired by a mental health
professional, but the group can also decide to have a patient
or family member to chair the meeting or to rotate that
role. The meetings follow some basic rules ensuring mutual
respect, but are otherwise flexible to accommodate the pri-
orities and wishes of the participants. For the proposed re-
search studies, mental health professionals can be
psychiatric community officers, occupational therapists, so-
cial workers, nurses, psychiatrists or psychologists.
In Bosnia-Herzegovina, family involvement will be
tested in an exploratory RCT where 72 patients with
schizophrenia and non-affective psychosis (ICD-10 F20–
29) will be recruited and randomly allocated either to
family involvement or the control group without family
involvement, whilst both groups otherwise continue to
receive treatment as usual. In Colombia and Uganda the
intervention will be tested in open trials with 30 patients
(ICD-10 F20–29, F30-F39) each. In Colombia the trial
will be non-controlled. The study design in Uganda in-
cludes an additional control site against which patient
outcomes will be compared. This control site in Uganda
will recruit 30 patients who will continue to receive
treatment as usual and will be followed up at the same
time points as the intervention participants.
Across all the family involvement studies, the same
mental health professional will participate in a maximum
of two multi-family groups. This is to avoid any overall
effect being dominated by the influence of only one or
two individual professionals.
Volunteer support
Unpaid volunteers (rather than professionals) are linked with
one or more patients to provide psychological, social and
practical support, a concept that is often referred to as
befriending. The support may be focused on talking, joint ac-
tivities, expanding social networks or practical support (such
as vocational rehabilitation). Volunteer support in befriend-
ing programmes is supposed to benefit the patient as well as
the volunteer and to strengthen the cohesion and acceptance
of patients with mental disorders in the community. Whilst
the effects on volunteers themselves and on wider communi-
ties have not been systematically studied, there is some evi-
dence suggesting benefits for patients [10–12].
For the proposed research studies, volunteers will be
drawn from different backgrounds including university
students, the general public and religious communities.
All volunteers will be provided with a short training before
beginning the intervention and are expected to meet with
their matched patients every two weeks for six months.
The study design used to test the volunteer support inter-
vention varies across countries. In Bosnia-Herzegovina, a
RCT will be conducted with 72 patients (ICD F20–29) who
will be allocated to have one-to-one meetings with a volun-
teer or to a control group without any volunteer input.
Both groups will continue to receive treatment as usual.
Similar to the study on family involvement, the study
design for volunteer support in Colombia and Uganda will
be open trials with 30 patients. In Colombia the trial will
be non-controlled whereas in Uganda patient outcomes
will be compared to the aforementioned control group.
For both countries, two volunteers will meet small groups
of three to six patients. The proposed activities vary: in
Uganda the intervention will focus on one or two of the
following tasks i) increasing social activity/interactions; ii)
engaging in productive, e.g. income-generating, activities;
iii) providing practical support for accessing and utilising
available professional services and care; and iv) referrals to
such services if and when appropriate. It will be up to each
group of patients and volunteers to decide which of these
tasks to focus on. In Bosnia-Herzegovina and Colombia,
the intervention is focused more towards social activities/
interactions e.g. visiting parks, museums, and going to
cafes. As music and art plays a strong role in the Colom-
bian culture, the social activities may involve producing
art and music.
Patients and timescale
Patients are eligible if they are 18–65 years of age, have
been diagnosed with the type of SMI required in each
study, are currently outpatients, and have capacity to
provide informed consent. Exclusion criteria are any
cognitive impairment that would compromise valid re-
search assessments.
The time period for all interventions will be six
months. After the six months intervention period, pa-
tients, volunteers, family members and professionals are
free to continue with the given intervention, in the ori-
ginal or a different form and in any frequency that the
participants may wish to use. After the six months test
period the interventions will receive minimal or no sup-
port from the research team.
Data collection for all participants in all studies will take
place at baseline, at the end of the intervention period (six
months) and at follow up (twelve months). All assess-
ments for data collection will be conducted by trained re-
searchers with no involvement in the usual treatment of
the patients or the tested interventions. Adherence to the
intended intervention will be assessed in all trials.
In the RCTs, clinicians and participants cannot be
blinded towards the allocation of the patients to the ex-
perimental or control group. However, researchers who
conduct the outcome assessments will be blinded to the
allocation of patients. Moreover, all baseline assessments
will occur prior to randomisation. Randomisation will be
conducted by an independent researcher who will use
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sequential computer generated random numbers to de-
termine allocation. The allocation information will be
provided to the unblinded research coordinator at each
site. The intervention period begins from the date of
randomisation and for all other trials, i.e. non-RCTs, the
intervention period begins with the first multi-family
meeting or the allocation of patients and volunteers. A
summary of the schedule for patients in all DIALOG+
RCTs and Family Involvement and Volunteer Support
RCTs in Bosnia-Herzegovina can be found in Tables 2, 3
and 4 respectively.
Measures
Data will be collected using a standardised Case Report
Form (CRF) and each partner site will be collecting the
same core outcome measures for all recruited patients. All
CRFs have been translated into the relevant local lan-
guage. Country specific CRFs are available upon request.
At baseline, we will obtain socio-demographic and clin-
ical characteristics including gender, age, ethnicity, high-
est level of education, employment, mental and physical
diagnoses. Further assessed socio-demographic and clin-
ical data vary slightly across countries to capture the
most locally relevant information.
At baseline, six and twelve months we will assess:
Subjective quality of life using the Manchester Short
Assessment of Quality of Life (MANSA) [13]. The
MANSA has been widely used in mental health research
and contains satisfaction items with 12 life domains
which are rated by the patient between 1 (most negative
score) and 7 (most positive score). The mean score of
those 12 items is used to reflect subjective quality of life.
In all trials, the MANSA will be used as the primary
outcome at six months and in all controlled trials, the
MANSA is also used as a screening tool. To avoid in-
cluding patients with high levels of subjective quality of
life at baseline that cannot substantially improve during
the study anymore, only patients with a mean score of <
5 are eligible to take part in the study.
Mental Health Symptoms will be observer rated on the
24-item Brief Psychiatric Rating Scale (BPRS) [14]. Each
symptom is assessed and rated between 1 (not present)
and 7 (extremely severe) using a scoring guide. The
BPRS guide has been translated into the local languages,
and all researchers will be trained in BPRS assessments
and interrater-reliability will be established prior to base-
line data collection.
Objective Social Outcomes will be assessed using the
SIX which ranges from 0 (poorest social situation) to 6
(best social situation) and captures whether patients are
in employment, have independent accommodation, are
living with others and have contacts with friends [15].
Use of mental health services will be documented
on a simplified version of the Client Service Receipt
Inventory (CSRI) [16]. Information on medication
use, contact with mental health professionals and
any instances of hospitalisation in the last three
months will be recorded.
Table 2 Schedule of enrolment, interventions, and assessments for patients in the DIALOG+ study (all sites)
Timepoint Study period
Enrolment Allocation Post-allocation Close
out
-t1 Month 0 t1
Month
0
t2
Month
1
t3
Month
2
t4
Month
3
t5
Month
4
t6
Month
5
t7
Month
6
Flexible period
Month 7–12
Month
12
ENROLMENT:
Eligibility screen X
Informed consent X
MANSA Screening X
Allocation X
INTERVENTIONS:
DIALOG+ X X X X X X X X
DIALOG Scale – only in Uganda X X X X X X X X
Treatment as Usual – Bosnia and
Herzegovina and Colombia
X X X X X X X X
ASSESSMENTS:
Socio-demographic Questionnaire X
MANSA, BPRS, SIX, CSRI, Additional
measures (vary by site)
X X X
Adherence Measures X X X X X X X X
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Whilst the above measures are consistently used
across countries and studies, further measures are used
in only some studies to ensure data collection matches
local health priorities. These are listed in Table 5.
Sample size calculations
Formal sample size calculations were conducted for the
DIALOG+ RCTs in Uganda and Colombia in order to
detect a medium effect size of 0.5, setting power at 80%
for 5% significance. The total number of patients re-
quired is 64 per group (n = 128). After accounting for
clustering of patients treated by the same clinician,
based on an Intra-Cluster-Coefficient of 0.01 as observed
within the DIALOG+ trial in the UK [28], a conservative
design effect of 1.04, and allowing for a drop-out rate of
17%, a total of 168 patients will need to be recruited to
give an analysable sample of 140 (70 per group).
Estimates for exploratory randomised controlled trials
vary, but it has been suggested that a minimum of 30
participants per arm are required [29]. Therefore in
Bosnia-Herzegovina, the sample size for all RCTs include
36 per arm, to allow for a 20% drop out rate which has
Table 3 Schedule of enrolment, interventions, and assessments for patients in the Family Involvement Intervention in Bosnia-
Herzegovina
Timepoint Study period
Enrolment Allocation Post-allocation Close
out
-t1 Month 0 t1 Month
0
t2 Month
1
t3 Month
2
t4 Month
3
t5 Month
4
t6 Month
5
t7 Month
6
Flexible period Month
7–12
Month
12
ENROLMENT:
Eligibility screen X
Informed consent X
MANSA Screening X
Allocation X
INTERVENTIONS:
Family Involvement Sessions X X X X X X X X
ASSESSMENTS:
Socio-demographic
Questionnaire
X
MANSA, BPRS, SIX, CSRI,
ITAQ
X X X
Adherence Measures X X X X X X X X
Table 4 Schedule of enrolment, interventions, and assessments for patients of the Volunteer Support in Bosnia-Herzegovina
Timepoint Study period
Enrolment Allocation Post-allocation (weeks) Close
out
-t1 Month 0 t1
0
t2
2
t3
4
t4
6
t5
8
t6
10
t7
12
t8
14
t9
16
t10
18
t11
20
t12
22
t13
24
Flexible period Month
7–12
Month
12
ENROLMENT:
Eligibility screen X
Informed consent X
MANSA Screening X
Allocation X
INTERVENTIONS:
Volunteer Support Sessions X X X X X X X X X X X X X X
ASSESSMENTS:
Socio-demographic
Questionnaire
X
MANSA, BPRS, SIX, CSRI X X X
Adherence Measures X X X X X X X X X X X X X X
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been demonstrated in previous research with individuals
with psychosis [30].
For all other controlled and non-controlled trials, we
plan a sample size of 30 participants per arm or in total
respectively. Central limit theory suggests 30 as a mini-
mum sample size to enable meaningful parameter esti-
mates [31, 32].
The plan to have larger studies on DIALOG+ than on
family involvement and volunteer support reflects a par-
ticular interest of stakeholders in each country who felt
that DIALOG+ may play an important role in the fur-
ther development and establishment of community men-
tal health care in the participating countries.
Experiences with the interventions
At the end of the six month intervention period, a subset of
participants (patients, clinicians, family members/friends
and volunteers) who were allocated to the interventions will
complete semi-structured, in-depth interviews about their
experiences of receiving the interventions, with unblinded
researchers. Purposive sampling will be employed to cap-
ture patients with varying levels of engagement with their
clinician/volunteer/family group and with different out-
comes. The interviews will be audio recorded, transcribed
and analysed using the thematic analysis framework pro-
posed by Braun and Clarke [33].
Commonalities and differences
Whilst the type of interventions, target groups of pa-
tients with SMI, timelines and core outcome criteria are
consistent across all studies in all countries, there are
differences in the precise diagnostic inclusion criteria,
the study designs and some outcome criteria. The most
important commonalities and differences of the studies
in the three countries are summarised in Table 6
Settings
In Bosnia and Herzegovina, all research activities will take
place at the Clinical Centre University of Sarajevo.
In Colombia, the DIALOG+ study will take place at
various sites in Bogotá (San Ignacio hospital, Clínica la
Inmaculada, Clínica Fray Bartolomé) and Hospital Depar-
tamental Psiquiátrico Universitario del Valle ESE, Cali.
The Family involvement and Volunteer support studies
will recruit patients mainly from the Association of Per-
sons with Schizophrenia and their Families and the Bipo-
lar Patients Association, but they will also accept referrals
from the participating research sites in Bogotá.
In Uganda, the DIALOG+ study will take place in
Kampala at Butabika Mental Health Hospital and its sur-
rounding outreach clinics. Three mental health clinics (or
centres) in different areas of the country were randomised
Table 5 Additional outcome measures to be collected within each country
Additional Outcome Measures Bosnia-
Herzegovina
Uganda Colombia
Patients Internalised Stigma of Mental Illness Inventory [17] Volunteer
Support
All studies Volunteer
Support
Scale to Assess Therapeutic Relationships in Community Mental Health
Care (STAR-P) [18]
DIALOG+
Client Satisfaction Questionnaire-8 (at 6 and 12 months) [19] All studies
Self-Esteem Rating Scale [20] All studies
Depression and Anxiety Stress Scale [21] DIALOG+
Insight and Treatment Attitudes Questionnaire (ITAQ) [22] Family
Involvement
Medication Adherence Rating Scale [23] All studies
Clinicians Scale to Assess Therapeutic Relationships in Community Mental Health
Care (STAR-C) [18]
DIALOG+
Family Members/
Friends
Burden Scale for Family Caregivers [24] Family
Involvement
Community Attitudes Towards Mental Illness Scale [25] Family
Involvement
Zarit Burden Interview [26] Family
Involvement
Volunteers Community Attitudes Towards Mental Illness Scale [25] Volunteer
Support
Volunteer
Support
Social Distance Questionnaire [27] Volunteer
Support
Self-esteem Rating Scale [20] Volunteer
Support
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to one of three arms: Family involvement study (Masaka),
Volunteer support study (Jinja) and Control (Mitiyana).
Data management and analysis
All data will be collected on paper-based CRFs and
pseudonymised data will be entered onto a secure shared
electronic database, REDCap, accessible to all partners.
The electronic database will contain validations to en-
sure accurate data entry. Local coordinators and the UK
team will provide regular monitoring to ensure accurate
data collection and entry. All patient-identifiable data
will be pseudonymised and password-protected at the
local research site.
The studies will first be analysed separately, where the
mean MANSA score will be compared before and after
the intervention as well as between intervention and con-
trol arms (for all controlled studies). We will also combine
the datasets. The consistencies in the interventions and
study designs will make it possible to compare findings
and experiences and learn from commonalities and differ-
ences. Detailed statistical analysis plans will be completed
and signed off by all relevant partners prior to any data
analysis or unblinding of the data. Once signed off, the
plans will be available on request. The director of the
Group will have access to the final dataset.
Monitoring
An overall Advisory Group has been established for the
whole research programme of the NIHR Global Health
Research Group. It comprises members who are inde-
pendent of the organisations involved in the research.
Members have expertise in mental health care in the
partner countries, global mental health, research meth-
odology and implementation of study designs, including
RCTs, in community settings. Their role is equivalent to
a Steering Group and covers the research programme as
a whole, as well as individual studies. A formal Data
Monitoring Committee was not established as this func-
tion will be covered by the Advisory Group, who will
provide input on data monitoring, if and as required.
Dissemination
The findings will be disseminated to national stake-
holders, including policy makers, mental health workers
and the general public. Dissemination events will be held
in each country. The findings will be shared with the sci-
entific community in national and international confer-
ences and in open access publications. The general
availability of the data sets varies in line with the condi-
tions set by local ethics committees and research gov-
ernance rules. Yet, all data sets will be made available
upon request subject to data sharing agreements.
In addition to the findings of the studies themselves, we
will also publish reflective articles about the experiences
with refining interventions and study designs in partner-
ship with national stakeholders and conducting studies
with similarities and differences across three LMICs.
Discussion
The approach of the research group to establish a partner-
ship across countries on three continents and explore
resource-oriented interventions for community mental
health care for people with SMI has led to nine separate
study protocols. The content and design of the studies
were developed in workshops, consultations and discussion
groups at all sites. In each LMIC, each considered inter-
vention was discussed in depth and in partnership with
local stakeholders considering the local context, healthcare
priorities, practicalities and logistics of conducting the re-
search studies, as well as potential study sites, participants
and study designs. Workshop attendees included different
groups of mental health professionals, researchers, govern-
ment officials and representatives, volunteers, peer support
workers, representatives from patient and family organisa-
tions, non-government organisations and student organisa-
tions. These events and regular on-going communication
among all partners led to protocols for the three types of
resource-oriented interventions and for studies testing
them.
The study designs which are non-controlled or non-
randomised may provide limited conclusions on effect-
iveness whilst the exploratory RCTs have relatively small
sample sizes providing limited statistical power for de-
tecting effects. However, we believe they will provide
valuable insight into the feasibility and acceptability of
such interventions in the relevant contexts.
Table 6 Similarities and differences across the nine research
studies in three LMICs
Consistent Variable
Intervention period for 6 months
Principles of interventions Details of interventions
Patients with severe mental illness Precise diagnostic groups
Outcome assessments Trial designs:
- Baseline
- 6 months (post-intervention)
- 12 months
- Non-controlled, non-randomised
controlled and RCTs
- Sample sizes
- Blinded and non-blinded
Core outcome criteria: Further outcome criteria includes:
- Objective social situation (SIX) - Caregiver burden
- Subjective quality of life (MANSA) - Stigma
- Symptoms (BPRS) - Medication adherence
- Service use (CSRI adapted) - Self esteem
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The protocols show substantial consistencies across
the three LMICs but at the same time, there are a num-
ber of variations reflecting different contexts of national
health and social care systems and the specific priorities
and wishes of national stakeholders. This approach is
distinct from a conventional multi-centre study and re-
quired excellent collaboration and communication both
across and within the partner countries. Each of the nine
studies will primarily be analysed separately. Yet, the
consistencies in the interventions and the study designs
will make it possible to compare findings and learn from
commonalities and differences in the findings and expe-
riences. To our knowledge, this is an unusual and some-
what innovative approach in global mental health
research. The results of the studies may show to what
extent such designs across several countries do or do
not reveal additional insights. The approach also ensured
a relevance to the different national contexts so that the
findings can potentially impact on health policies and
clinical practice in each country.
Through these research studies and activities, the Group
aims to encourage sharing and learning across contexts
thereby building sustainable research capacity and exploring
and deepening the understanding of global mental health.
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